BlackRock Amends Orthofix Stake, Signals Passive Investment Update
Ticker: OFIX · Form: SC 13G/A · Filed: Jan 8, 2024 · CIK: 884624
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Orthofix, watch for market reaction.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 8, 2024, indicating a change in its ownership of Orthofix Medical Inc. common stock as of December 31, 2023. This filing, Amendment No. 4, updates BlackRock's previous disclosures regarding its passive investment in Orthofix. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or investment strategy, potentially influencing other investors' perceptions of Orthofix Medical Inc.
Why It Matters
This filing shows BlackRock's updated, passive ownership in Orthofix, which can influence market sentiment and signal institutional confidence in the company's future.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued, albeit updated, passive stake in Orthofix, but this filing alone doesn't warrant immediate action without further details on the percentage of ownership, which is not provided in this excerpt.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person filing the SC 13G/A
- Orthofix Medical Inc. (company) — the issuer whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 8, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 4 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4)' sections.
Who is the reporting entity in this filing?
The reporting entity is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What company's stock is the subject of this filing?
The subject company is Orthofix Medical Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Orthofix Medical Inc.'
What was the date of the event that triggered this filing?
The date of the event which requires the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement)'.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Orthofix Medical Inc. is 68752M108, as listed under '(CUSIP Number)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 8, 2024 regarding Orthofix Medical Inc. (OFIX).